WEB only

Farmak closes M&A deals in the Czech Republic, Slovakia and Ukraine

Farmak increases its presence in the EU countries by acquiring pharmaceutical marketing companies in the Czech Republic and Slovakia, together…

WEB only

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer…

WEB only

Conversations about pharmaceutics: a series of podcasts “Unmute”created by Darnytsia and UPSA-Kyiv

Pharmaceutical company “Darnytsia” together with the Ukrainian Pharmaceutical Students’ Association (UPSA) are preparing a series of podcasts about pharmaceutics. Company…

WEB only

When can single-arm trials support drug filings?

The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group…

WEB only

Reka-Med to the YURіA-PHARM group of companies

Together, we will continue scaling up our activities in the countries of Central Asia. The role of Reka-Med is a…

WEB only

EURIZON FELLOWSHIP PROGRAMME: “Remote Research Grants for Ukrainian Researchers”

The EURIZON WP9 secretariat is pleased to announce the launch of the new EURIZON Fellowship Program: “Remote Research Grants for Ukrainian…

WEB only

“Darnitsa” joined the London Chamber of Commerce and Industry

The pharmaceutical company Darnitsa, a leading manufacturer of medicines in Ukraine, announced that it has entered into the London Chamber…

WEB only

Bormioli Pharma grows in North America, with a 40% sales increase in 2022

Bormioli Pharma, an international leader in the production of pharmaceutical packaging and medical devices, today announced robust growth in its…

WEB only

New technical regulations for aerosol dispensers approved in Ukraine

The Resolution of the Cabinet of Ministers of Ukraine No. 154 dated by February 21, 2023, approved the Technical Regulations…

WEB only

Marchesini Group acquires Milan-based company M.A.R. S.p.A.

A new company is joining Marchesini Group. The latest arrival is M.A.R. S.p.A., a company from Lainate (Milan) specialised in…

Objective informational resource
for industry professionals

Farmak closes M&A deals in the Czech Republic, Slovakia and Ukraine

Boehringer Ingelheim inaugurates largest European development centre for biotechnology

Conversations about pharmaceutics: a series of podcasts “Unmute”created by Darnytsia and UPSA-Kyiv

When can single-arm trials support drug filings?

Reka-Med to the YURіA-PHARM group of companies

EURIZON FELLOWSHIP PROGRAMME: “Remote Research Grants for Ukrainian Researchers”

“Darnitsa” joined the London Chamber of Commerce and Industry

Bormioli Pharma grows in North America, with a 40% sales increase in 2022

New technical regulations for aerosol dispensers approved in Ukraine

Marchesini Group acquires Milan-based company M.A.R. S.p.A.

Menu

Rubrics

Подобається наш журнал! Розкажи про нас